Extension Study of Talampanel for Amyotrophic Lateral Sclerosis

- Amyotrophic Lateral Sclerosis
- Terminated

Study Title: Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Teva Identifier: ALS-TAL-201-OL

ClinicalTrials.gov Identifier: NCT00982150

Study Status: Terminated

Trial Condition(s): Amyotrophic Lateral Sclerosis

Interventions: Drug: Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 80 Years

Trial Duration: 09/01/2009 - 06/01/2010

Phase: Phase 2

Study Type

Interventional